Showing results (81-90 of 2,811) with videos related to
Sort By:
Pageof 282
Diabetes Technology & Therapeutics|August 3, 2018
Risk Factors of Hypoglycemia in Patients with Type 2 Diabetes Mellitus: A Study Based on Continuous Glucose MonitoringKeiichi Torimoto, Yosuke Okada, Maiko Hajime, et al.Diabetes Technology & Therapeutics|August 17, 2019
Adoption of New Glucose-Lowering Medications in the U.S.-The Case of SGLT2 Inhibitors: Nationwide Cohort StudyRozalina G McCoy, Hayley J Dykhoff, Lindsey Sangaralingham, et al.Diabetes Technology & Therapeutics|March 6, 2019
Continuous Glucose Monitoring Linked to an Artificial Intelligence Risk Index: Early Footprints of Intraventricular Hemorrhage in Preterm NeonatesAlfonso Galderisi, Luca Zammataro, Eleonora Losiouk, et al.Diabetes Technology & Therapeutics|November 22, 2018
Prevalence of Diabetic Neuropathy in Young Adults with Type 1 Diabetes and the Association with Insulin Pump TherapyMarie Mathilde Bjerg Christensen, Eva Elisabeth Hommel, Marit Eika Jørgensen, et al.Diabetes Technology & Therapeutics|January 22, 2021
Standardizing Reporting of Glucose and Insulin Data for Patients on Multiple Daily Injections Using Connected Insulin Pens and Continuous Glucose MonitoringDavid Rodbard, Satish K GargDiabetes Technology & Therapeutics|February 5, 2021
Prevalence of SARS-CoV-2 Antibodies in Children and Adults with Type 1 DiabetesXiaofan Jia, Patricia Gesualdo, Cristy Geno Rasmussen, et al.Diabetes Technology & Therapeutics|March 7, 2017
A Clinical Trial of the Accuracy and Treatment Experience of the Flash Glucose Monitor FreeStyle Libre in Adults with Type 1 DiabetesArndís F Ólafsdóttir, Stig Attvall, Ulrika Sandgren, et al.Diabetes Technology & Therapeutics|March 11, 2017
A Fixed Ratio Combination of Insulin Degludec and Liraglutide (IDegLira) Reduces Glycemic Fluctuation and Brings More Patients with Type 2 Diabetes Within Blood Glucose Target RangesAllen B King, Athena Philis-Tsimikas, Eric S Kilpatrick, et al.Diabetes Technology & Therapeutics|March 11, 2017
Pregnancy Outcomes and Insulin Requirements in Women with Type 1 Diabetes Treated with Continuous Subcutaneous Insulin Infusion and Multiple Daily Injections: Cohort StudySally K Abell, Matthew Suen, Anthony Pease, et al.Diabetes Technology & Therapeutics|March 1, 2017
Real-World Use and Self-Reported Health Outcomes of a Patient-Designed Do-it-Yourself Mobile Technology System for Diabetes: Lessons for Mobile HealthJoyce M Lee, Mark W Newman, Achamyeleh Gebremariam, et al.Pageof 282